Clinical Trials Browser

Phase 2 × Neovascularization, Pathologic × Bevacizumab × Clear all

NCT00162669 2006-09-08

Bevacizumab in Advanced Hepatocellular Carcinoma

Phase 2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Neovascularization, Pathologic